CIRCLE. To read the survey conducted in "Les Echos" (19/05/2010 and 20/05/2010, cf. Proposed link), the French research in the life sciences and health décrocherait inevitably not only outstripped by some leading countries of science as the United States, England, Germany and Japan, but caught or overtaken by outsiders such as Switzerland or Sweden.Actually, this is a simplistic analysis, which is first to measure the effectiveness of our research for the sole bibliometric reading, then do consider it only in terms criteria ignoring some French specificities to finally ignore with great effort, newer and sometimes more dramatic to improve the governance of our research and even beyond its effectiveness.
What then of our research in France Life Sciences and Health? What about the place in an international competition where the United States come to invest at the stimulus package President Barack Obama ten billion additional dollars in addition to thirty billion existing NIH? Beyond only bibliometric criteria, against which (we'll) France is far from occupying the site confusing that some want a little too quickly assign the dynamism of research can be measured using other markers.
For even essential, bibliometrics can not be the sole criterion for assessing the strength of the research. France, for example, has to rank for the second consecutive year 1 among European nations by its success rate in tenders "young researchers in life sciences" of the European Research Council. A result that undoubtedly reflects the attractiveness of our laboratories. France also has a leading role in the construction of the European Research Area: We dirigeonsla first pilot joint programming initiative dedicated to neurodegenerative diseases, particularly Alzheimer's disease, and coordinate two European infrastructure of primary importance, designed to create a network of clinical research centers and laboratories, high biosafety. From this point of view, the culture of major programs gives us a substantial advantage to enter the ground floor in this "big science" that become biomedical research.
The business of research in the life sciences and health, including basic research and beyond, so the only medical advances, has a major impact socioécononomique. Technological development activities and education, involvement in expertise, related associations and, more generally, the dissemination of knowledge are all criteria that we must take into account the evaluation of researchers.
Multivariate Statistics for Wildlife and Ecology Research
"It" doesn't exist in any known medical2006-06-12 21:38:07 by Phrend
Or manifest physical sense of that. Which, as usual, makes taking drugs a shot in the dark on a guess, at best.
For more info from a genuine brain doctor, a neurologist and specialist:
"They made a list of the most common symptoms of emotional discomfiture of children; those which bother teachers and parents most, and in a stroke that could not be more devoid of science or Hippocratic motive--termed them a 'disease.' Twenty five years of research, not deserving of the term 'research.,' has failed to validate ADD/ADHD as a disease. Tragically--the "epidemic" having grown from 500 thousand in 1985 to between 5 and 7 million today--this remains the state of the 'science' of ADHD
Hi Boomers. I am not of your "group",2008-01-17 12:53:17 by noncomposmenace
But have a question for you. I am interested in using my skills as a crack medical researcher to help people work their ways through medical crises. I am particularly good at finding cutting edge doctors for second opinions, facilities offering the best (and often not revealed to one by one's doctor) treatment options available, etc. I have done this for decades for family and friends, and I realize that not everyone is as adept in these areas as I. This type of service is beine offered at present only to the billionaires of our country, to the tune of an initiation fee of from $10,000 to $20,000, and with subsequent annual fees of from $5,000 to $30,000
Cont'd....2009-07-07 18:28:09 by The_Man
Comparing the relative effectiveness of treatments and drugs will lead to rationing.
This issue flared up because Congress recently approved more funding for "comparative-effectiveness research." The term refers to studies to evaluate which drugs or treatments work best for different medical conditions and different patients. That's one more piece of informationbased on science, not drug-company advertising or sales reps pushing pillsto help your doctor and you decide what's right. Consumers Union has long argued for better health-care information
Their best resource2006-07-15 17:12:44 by NeighborhoodBully
Israel, the 100th smallest country,
> with less than 1/1000th of the world's population, can
> make claim to the following:
An Israeli company has unveiled a blood test that via
> the telephone diagnoses heart attacks.
> The Israeli-developed Ex-Press shunt is providing
> relief for American glaucoma sufferers.
> An Israeli research team has found that the
> combination of electrical stimulation and chemotherapy
> makes cancerous metastases disappear.
> Israel has designed the first flight system to
> protect passenger and freighter aircraft against
> missile attack
You might also like:
USAMRIID scientists closer to cure for Ebola virus, new study says — Frederick News Post
In a study led by the U.S. Army Medical Research Institute for Infectious Diseases and published in Science Translational Medicine, 43 percent, or three out of seven infected monkeys, recovered in 104 to 120 hours after intravenous treatment.
Texas A&M Research Aids Military in Fighting Brucellosis on the Battlefield — KBTX
She will continue to contribute to ongoing projects with U.S. Army Medical Research Institute of Infectious Diseases for controlled release viral vaccines.
Etymotic Research ER-4PT MicroPro Noise-Isolating In-Ear Earphones (Black)
CE (Etymotic Research)